T cell hyperproliferation is also observed in patients with ALPS (2, 4), an autoimmune disease characterized by defective Fas/FasL signaling or by other genetic defects associated with the Fas/FasL pathway. Here, FASLG is linked to autoimmune lymphoproliferative syndrome.